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Background: Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. Early
detection and treatment of dyslipidemia in type-2 diabetes mellitus can prevent risk for atherogenic cardiovascular
disorder. The rationale of this study was to detect the lipid abnormality in diabetic patients.
Methods: Necessary data was collected from the medical archives of 150 patients (73 female and 77 male) with
diabetes mellitus registered in Department of pathology and biochemistry of a Ayurveda hospital established at
Kolkata, India.
Results: The mean ages of female and male subjects were 51.8 ± 10.8 and 53.2 ± 11.3 years respectively. The range
and mean value of FBS in females were 113–342 mg/dl and 157.7 ± 6.3 mg/dl, while the range and mean value of
PPBS in females were 135–560 mg/dl and 275.5 ± 12.3 mg/dl respectively. Results showed that range and mean
value of FBS in males were 111–462 mg/dl and 160.8 ± 7.4 mg/dl, while the range and mean value of PPBS in
males were 136–598 mg/dl and 302.1 ± 12.6 mg/dl respectively. Results of serum lipids showed that the mean
values for total cholesterol (TC), triglyceride (TG), high density lipoprotein cholesterol (HDL-C), low density
lipoprotein cholesterol (LDL-C) and very low density lipoprotein cholesterol (VLDL-C) in female patients were
202.2 ± 5.9 mg/dl, 168.3 ± 8.2 mg/dl, 44.9 ± 1.3 mg/dl, 123.6 ± 5.2 mg/dl and 33.7 ± 1.7 mg/dl respectively. The mean
values for TC, TG, HDL-C, LDL-C and VLDL-C in male patients were 182.5 ± 4.8 mg/dl, 128.1 ± 10.8 mg/dl, 40.8 ± 1.2 mg/dl,
105.4 ± 4.8 mg/dl and 36.2 ± 2.2 respectively. FBS showed significant positive correlation with PPBS, cholesterol, TG, and
VLDL-C. PPBS also demonstrated direct and significant correlations with TG and VLDL-C.
Conclusions: The study showed common lipid abnormalities during diabetes induced dyslipidemia
i.e., hypercholesterolemia, hypertriglyceridemia and elevated LDL-C. This study suggests the dominance of
hyperlipidemia over increased prevalence of dyslipidemia.
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The frequency of diabetes mellitus is increasing many
folds in South Asian population due to the high degree
of genetic predisposition and high susceptibility to envir-
onmental insulin, characterized by a high BMI, high upper
body adiposity, a high body fat percentage and a high
level of insulin resistance [1]. All forms of diabetes are
characterized by absolute or relative deficiencies in insulin
secretion and/or insulin action associated with chronic* Correspondence: deepdixit20@gmail.com
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unless otherwise stated.hyperglycemia and disturbances of carbohydrate, lipid and
protein metabolism [2]. The chronic hyperglycemia of dia-
betes is associated with long-term damage, dysfunction,
and failure of various organs, especially the eyes, kidneys,
nerves, heart, and blood vessels [3].
Research finding shows that it is the body composition
components, mainly body fat and lipid profiles that are
responsible for increase prevalence of this disease [2,4].
he term “dyslipidemia” is increasingly popular to describe
abnormal changes in lipid profile, replacing the old term
“hyperlipidemia”. Dyslipidemia encompasses changes in
High density lipoprotein cholesterol (HDL-C), the size
and density of Low density lipoprotein cholesterol (LDL-d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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triglyceride level [5-7]. The term diabetic dyslipidemia
comprises a triad of raised triglycerides, reduced HDLC
and excess of small, dense LDL particles. The lipid abnor-
malities are prevalent in diabetes mellitus because insulin
resistance or deficiency affects key enzymes and pathways
in lipid metabolism [8]. In particular, the following pro-
cesses are affected: apoprotein production, regulation of
lipoprotein lipase, action of cholesteryl ester, transfer pro-
teins and hepatic and peripheral actions of insulin [4,5].
Even more, it has been proposed that the composition of
lipid particles in diabetic dyslipidemia is more atherogenic
than other types of dyslipidemia [9]. This means that even
normal lipid concentrations might be more atherogenic in
diabetic than in nondiabetic people. The causal associ-
ation between atherosclerosis and dyslipidemia is well
established. In diabetes the associated hyperglycemia,
obesity and insulin changes highly accelerate the progres-
sion to atherosclerosis [10,11].
Therefore, present study was carried out to find asso-
ciation/relation between serum lipid profile and blood
sugar, in view of the hypothesis that early detection and
treatment of lipid abnormalities can minimize the risk
for atherogenic cardiovascular disorder and cerebrovas-
cular accident in type-2 diabetic patients. Hence, the ra-
tionale of this study was to detect dyslipidemia in
patients with type-2 diabetes mellitus.
Material and methods
Chemical
The diagnostic kits i.e. Glucose, Cholesterol, triglyceride,
HDL-C, LDL-C VLDL-C and reagents were procured
from Siemens Ltd, (Gujrat India). All the reagents were
stored at 2-8ºC after procurement. All the biochemical
estimations were performed at room temperature.
Subjects
It is a retrospective study based on the available biochem-
ical data of type-2 diabetic patients visiting the Biochemis-
try department for the diagnosis of blood sugars and lipid
profile, after prescription and medication from OPD and
IPD of the Ayurveda hospital at Kolkata, India. A total of
150 diabetic patients (73 females and 77 males) with age
range of 36–75 years and with history of diabetes for more
than 4 years were randomly selected from the medical re-
cords. Patients reported with other ailments and metabolic
disorders were excluded from the study. The individual in-
formation about clinical symptoms, weight, height and
diagnosis by the hospital physicians were well documented
in medical records of the hospital.
Estimation of blood sugar
Venous blood samples were collected from all the sub-
jects in the morning after fasting overnight. The plasmawas later used for analyzing FBS and PPBS. Plasma glu-
cose was measured by Glucose oxidase and peroxidase
(GOD-POD) method. It is based on the principle that
glucose is oxidized by glucose oxidase into gluconic acid
and hydrogen peroxide. Hydrogen peroxide in presence
of peroxidase oxidizes the chromogen 4-aminoantiyrine/
phenolic compound to a red colored compound. The in-
tensity of the red colored compound is proportional to
the glucose concentration and is measured at 505 nm
using a semi-automated enzymatic analyzer (Robonik,
Mumbai, India).
Estimation of total cholesterol
Cholesterol esters will be hydrolyzed by cholesterol ester-
ase. Cholesterol will be oxidized into cholest-4-en-3-on
and hydrogen peroxide by bacterial cholesterol oxidase.
Hydrogen peroxide in the presence of phenol and amino-
4-antipyrine forms a complex of red color showing ab-
sorption maximum between 500–550 nm.
Estimation of triglyceride: It is based on the principle
that triglycerides in the serum sample are hydrolyzed enzy-
matically by the action of lipase to glycerol and fatty acids.
The glycerol formed is converted to glycerol phosphate by
glycerol kinase (GK). Glycerol phosphate is then oxidized
to dihydroxyacetone phosphate by glycerol phosphate oxi-
dase (GPO). The librated hydrogen peroxide is detected by
a chromogenic acceptor, chlorophenol-4-aminoantipyrine,
in the presence of peroxidase (POD). The red quinone formed
is proportional to the amount of triglycerides present in
the sample and is measured at 546 nm.
Estimation of total HDL-cholesterol: It is measured by
using phosphotungstate precipitation method based on
the principle that chylomicrons, VLDL and LDL frac-
tions in serum or plasma are separated from HDL by
precipitating with phosphotungstic acid and magnesium
chloride. After centrifugation the cholesterol in the HDL
fraction which remains in the supernatant is assayed
with enzymatic cholesterol method using cholesterol es-
terase, cholesterol oxidase, peroxidase and the chromo-
gen 4-aminoantipyrine.
Estimation of total LDL-cholesterol: The LDL-Cholesterol
test is a two reagent homogenous system. The assay is
comprised of two distinct phases. In phase one a unique
detergent solubilizes cholesterol from non-LDL-lipoprotein
particles. This cholesterol is consumed by cholesterol ester-
ase, cholesterol oxidase, peroxidase and 4-aminoantipyrine
to generate a colorless end product. In phase two a second
detergent in reagent 2 releases cholesterol from the
LDL–lipoproteins. This cholesterol reacts with choles-
terol esterase, cholesterol oxidase and a chromogen sys-
tem to yield a blue color complex which can be measured
bichromatically at 540/660 nm. The resulting increase in
absorbance is directly proportional to the LDL-C concen-
tration in the sample.
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cholesterol was calculated as one-fifth of the concentra-
tion of triglycerides.
Statistical analysis
The data obtained was analyzed for significance between
the groups by one-way analysis of variance (ANOVA). Cor-
relation studies (Pearson’s correlation coefficients and sig-
nificance) were performed between the variables of blood
sugar and serum lipid profile by using statistical software
programme “SPSS evaluation version 22”.
Results
Results of the retrospective study showed that among
150 patients of diabetes mellitus included in this study,
female and male were 73 and 77 respectively (Table 1).
The age range and mean age of female subjects was 40–75
years and 51.8 ± 10.8 while the age range and mean age
for male subjects was 36–72 years and 53.2 ± 11.3 years,
respectively.
Results of the blood sugar profile showed that all indi-
viduals were hyperglycaemic. The range and mean value
of FBS in females were 113–342 mg/dl and 157.7 ±
6.3 mg/dl, while the range and mean value of PPBS in
females were 135–560 mg/dl and 275.5 ± 12.3 mg/dl re-
spectively. Results showed that range and mean value of
FBS in males were 111–462 mg/dl and 160.8 ± 7.4 mg/dl,
while the range and mean value of PPBS in males were
136–598 mg/dl and 302.1 ± 12.6 mg/dl respectively
(Table 2). It was observed that some patients have con-
trolled FBS, but there PPBS was uncontrolled. Therefore,
the range of FBS in some patients looks nearly normal or
controlled, while in few patients it was uncontrolled. Re-
sult also showed that PPBS were slightly higher in males
as comparison to female madhumeha patients.
Results of serum lipid profile showed that the means
values for TC, TG, HDL-C, LDL-C and VLDL-C in female
patients were 202.2 ± 5.9 mg/dl, 168.3 ± 8.2 mg/dl, 44.9 ±
1.3 mg/dl, 123.6 ± 5.2 mg/dl and 33.7 ± 1.7 mg/dl respect-
ively. The means values for TC, TG, HDL-C, LDL-C and
VLDL-C in male patients were 182.5 ± 4.8 mg/dl, 128.1 ±
10.8 mg/dl, 40.8 ± 1.2 mg/dl, 105.4 ± 4.8 mg/dl and 36.2 ±
2.2 respectively. Results showed that diabetic females
have significantly higher (P < 0.05) TC, TG and LDL-C as
compared to male patients (Table 3). Among all patientsTable 1 Gender distribution and age of selected type-2
diabetes patients
Gender No. of patients Age1
Female 73 51.8 ± 10.8
Male 77 53.2 ± 11.3
Total 150 52.5 ± 11.1
1Units expressed as years.hypercholesterolemia was found in 79 (52.6%) individuals.
Similarly, hypertriglyceridemia was found in 95 (63.3%) in-
dividuals, and increased LDL-C was found in 108 (72.6%)
individuals.
In correlation studies, FBS showed significant positive
correlation with PPBS (P < 0.001), cholesterol (P < 0.05),
TG (P < 0.01) and VLDL-C (P < 0.001) (Table 4). PPBS
also demonstrated direct and significant correlations with
TG (P < 0.01) and VLDL-C (P < 0.01). The correlation of
cholesterol with TG (P < 0.001), LDL-C (P < 0.001) and
VLDL-C (P < 0.001) were positive. TG showed a signifi-
cant negative correlation with HDL-C (P < 0.01), while a
highly significant positive correlation was observed with
VLDL-C (P < 0.001). However, HDL-C showed a negative
correlation with LDL-C and VLDL-C (P < 0.01).
Discussion
The relation between diabetes mellitus and serum lipid
profile had been much discussed during the past decades
[4,5,12,13]. Both lipid profile and diabetes have been
shown to be the important predictors for metabolic distur-
bances including dyslipidaemia, hypertension, cardiovas-
cular diseases, hyperinsulinemia, etc. [6]. Dyslipidemia as
a metabolic abnormality is frequently associated with dia-
betes mellitus. Its prevalence is variable, depending on the
type and severity of diabetes, glycaemic control, nutri-
tional status, age and other factors. Earlier studies also
indicated a strong clustering risk factor for coronary
artery disease in diabetic subjects [4,11]. Over 70% of pa-
tients with type 2 diabetes mellitus had one or more types
of dyslipidemia. Similarly, our results reveal high preva-
lence of hypercholesterolemia, hypertriglyceridemia and
high LDL-C levels, which are well known risk factors
for cardiovascular diseases among patients. These pa-
tients are on high-risk without complications but already
had significant dyslipidemia, which enhances the risk
of cardiovascular events, certainly required therapeutic
intervention.
In diabetes many factors may affect blood lipid levels,
because of interrelationship between carbohydrates and
lipid metabolism. Therefore, any disorder in carbohy-
drate metabolism leads to disorder in lipid metabolism
and vice versa [14]. Insulin resistance is a primary de-
fects in the majority of with type-2 diabetes. In non dia-
betic individuals insulin resistance in combination with
hyperinsulinemia has a strong predictive value for future
development for type-2 diabetes [15]. Several studies
showed that insulin affects the liver apolipoprotein pro-
duction and regulates the enzymatic activity of lipopro-
tein lipase and cholesterol ester transport protein, which
causes dyslipidemia in diabetes mellitus. Moreover, insu-
lin deficiency reduces the activity of hepatic lipase and
several steps in the production of biologically active lipo-
protein lipase [4,5,7].
Table 2 The concentration of fasting blood sugar (FBS) and post prandial blood sugar (PPBS) in plasma of diabetic
patients
Gender Glucose (FBS)1 Glucose (PPBS)1
Normal range Calculated range Mean Normal range Calculated range Mean
Female 70-110 113-342 157.7 ± 6.3* 110-140 135-560 275.5 ± 12.3*
Male 70-140 111-462 160.8 ± 7.4* 70-140 136-598 302.1 ± 12.6*
1Units expressed as mg/dl.
*Statistically significant (P < 0.05) as compared to normal range for plasma blood sugar.
Dixit et al. Journal of Diabetes & Metabolic Disorders 2014, 13:58 Page 4 of 6
http://www.jdmdonline.com/content/13/1/58The result of the present study indicates that the most
common recognized abnormality was hypertriglyceridae-
mia. Other researchers also associated the high triglyceride
level to the poor glycaemic control of diabetes and obesity
[5,16]. This hypothesis is supported by the reduction of the
triglyceride level with the improvement of glycaemic con-
trol i.e. FBS and PPBS. Abbate and Brunzell reported that
the increase in triglycerides in poorly controlled patients
was related to the decrease of activities of adipose tissue
and muscle lipoprotein lipase activity [17].
A study by Packard et al., reported that reduced HDL-
C as a powerful predicator for premature coronary heart
diseases [18]. Goldberg reported that hyperglycemia pro-
gressively increases the transfer of cholesterol esters
from HDL-C to VLDL-C particles, hence, denser LDL
particles acquire a large proportion of these HDL esters,
further diminishing the HDL-C level [6]. In addition,
HDL-C is a ready substrate for hepatic lipase which con-
verts it into smaller particles, which are readily cleared
from the plasma [4,5]. As with the triglycerides, im-
provement in glycaemic control leads to an increase in
the levels of HDL-C, and suggest the evidence for a role
for poor glycaemia in decreasing the level of this lipo-
proteins. Poor insulinization results in increased lipolysis
in adipocytes. The resulting increase in fatty acid trans-
port to the liver, which is a common abnormality in type
2 diabetes, may cause an increase in VLDL-C. Insulin
directly degrades the apo B (which is the major protein
of VLDL particles) and thus insulin may increase secre-
tion of apo B (and then VLDL) [19]. In correlation studies,
our results were compatible with the finding of Rosediani
et al., who reported significant positive correlation of FBSTable 3 The concentration of cholesterol, triglyceride, HDL-Ch
of diabetic patients
Lipid parameter Female
Normal range Calculated range Mea
Total Cholesterol1 < 200 130-396 202.2
Triglyceride1 50-150 60-380 168.3
HDL-Cholesterol1 45-65 20-66 44.9
LDL-Cholesterol1 < 100 42-274 123.6
VLDL-Cholesterol1 15-30 12-76 33.7
1Units expressed as mg/dl.
*Statistically significant (P < 0.01) as compared to normal range for respective serumwith PPBS [20]. Results of our correlation studies dem-
onstrated significant positive correlation of blood sugar
with, cholesterol, TG and VLDL-C. Similarly, cholesterol
showed positive correlation with TG, LDL-C and VLDL-
C. Significant negative correlation of TG with HDL-C
in the present study was in agreement with the earlier
study of Mahato et al. [9]. However, HDL-C showed a
negative correlation with LDL-C and VLDL-C which. Re-
sults of the correlation studies suggest a clear association
between hyperglycemia and appearance of dyslipidemia.
Similarly, Tseng has also reported lipid abnormalities
in patients with type 2 diabetes with regards to differ-
ent stages of albuminuria and suggested a close link be-
tween uric acid and increased urinary albumin excretion
rate in type 2 diabetic patients of Taiwan [21,22]. Several
authors reported a positive improvement in lipid profile
with fair glycaemic control [3,23]. In uncontrolled diabetic
patients, it has been reported that the activity of lipopro-
tein lipase and hence clearance of VLDL-C in the circula-
tion is diminished due to insulin resistance. The level of
total cholesterol is usually normal or near normal if gly-
caemic control is adequate, and worsening of control
raises the level [24]. Therefore, improving glycaemic
control can substantially reduce the risk of cardiovas-
cular events in diabetic patients. As the occurrence of
dyslipidemia depends on factors such as insulin action
on peripheral tissues and liver, apoprotein production
and regulation of lipoprotein lipase, the duration of dia-
betes seems to play only a minor role in modifying these
factors [14]. In addition, clinicians tend to neglect looking
for other secondary causes of dyslipidemia, such as renal
disease, alcohol consumption and certain drugs. Theseolesterol, LDL-Cholesterol and VLDL-Cholesterol in serum
Male
n Normal range Calculated range Mean
± 5.9* < 200 100-295 182.5 ± 4.8*
± 8.2* 50-150 60-650 128.1 ± 10.8*
± 1.3 35–55 22-60 40.8 ± 1.2
± 5.2* < 100 26-237 105.4 ± 4.8*
± 1.7 15-30 12-130 36.2 ± 2.2
lipids.
Table 4 Correlation studies between the blood sugar and
serum lipid profile variables of diabetic patients
PPBS Cholesterol TG HDL-C LDL-C VLDL-C
FBS 0.633*** 0.167* 0.292** −0.021 0.072 0.292***
PPBS 0.063 0.249** 0.108 −0.051 0.249**
Cholesterol 0.317*** 0.103 0.931*** 0.317***
TG −.235** 0.009 1.000***
HDL-C −0.012 −0.235**
LDL-C 0.009
The values expressed as Pearson correlation coefficients.
*Correlation is significant at the 0.05 level.
**Correlation is significant at the 0.01 level.
***Correlation is significant at the 0.001 level.
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any stage of diabetes (i.e. irrespective of duration).
Dyslipidemia management in people with diabetes mel-
litus, just like in any other individual, starts with a thor-
ough evaluation that aims to identify secondary causes
that might contribute to the abnormal lipid profile [25].
Lifestyle changes, including increased physical activity and
dietary modifications, are the cornerstones of manage-
ment. The highest priority for diabetic individuals who
have poor glycaemic control should be to achieve near
normal blood glucose levels, in the expectation that this
approach will also improve dyslipidemia [5,26,27]. Our
study clearly shows that lipid fractions are abnormal in
diabetes mellitus. Realizing that most of the diabetics have
a high probability of developing cardiovascular and cere-
brovascular disease, it is essential that an individual who
is diabetic should take care of dyslipidemia. Our study
clearly suggests the dominance of hyperlipidemia over
increased prevalence of dyslipidemia. Prospective and
longitudinal studies are needed at the time of diag-
nose to estimate true population prevalence of dyslip-
idemia in patients with type-2 diabetes mellitus.
Conclusions
Present study showed common lipid abnormalities dur-
ing diabetes induced dyslipidemia are hypercholesterol-
emia, hypertriglyceridemia and elevated LDL-C. Results
suggest a high prevalence of dyslipidemia, which might
be playing a major role in the development of cardiovas-
cular diseases among diabetic patients. The optimal care
of diabetic patients should include routine monitoring of
blood sugar and serum lipid profile. Aggressive lifestyle
changes, such as weight reduction and physical exercise
should be initiated first followed by medication with
lipid lowering drugs. The optimum treatment with anti-
diabetic drugs to obtain fair glycaemic control should go
hand-in-hand with lipid-lowering drugs.Competing interests
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